explore -WSS

explore

author：Wikipedia 2025-10-02 21:06:29 - browse：843

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The drug industry has found itself all alone in Washington

WSS

With psoriasis trial ahead, Alumis raises $259 million

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

New study raises questions about niacin and heart health

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Reporting on presidential health from Reagan to Trump and Biden

MD Anderson's Padmanee Sharma responds to research credit suit

knowledge

explore

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Activists slam private health insurers over coverage restrictions

Amylyx ALS drug fails large clinical trial

Drug repurposing or repositioning? The language matters

First medicine developed to treat MASH expected to be approved soon

Walensky prepares to leave CDC — and Congress — behind

Hospitals are piloting generative AI tools as regulators play catch

Duchenne breakthrough therapy leaves behind pioneering families

Ukraine seeks to reclaim its role as a hub for clinical trials

Novavax promises a turnaround & Lilly roils the obesity market

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

entertainment

UnitedHealth quietly bought dozens of outpatient centers

UnitedHealth quietly bought dozens of outpatient centers

IVF, abortion rights issues kick off Biden’s State of the Union

Medicare Advantage enrollment grows 7.1% to 33.4 million people

WATCH: Why do our ears pop?

Medicare Advantage enrollment grows 7.1% to 33.4 million people

knowledge

hotspot

entertainment

knowledge